Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Correlation analyses of cric-ABCB10 expression and clinicopathologic parameters of CC patients

From: Circ-ABCB10 knockdown inhibits the malignant progression of cervical cancer through microRNA-128-3p/ZEB1 axis

Clinical characteristics

 

Circ-ABCB10

  

N

High expression N (%)

Low expression N (%)

Χ2

P

Age

 > 45

7

4 (57.1%)

3 (42.9%)

0.18

0.671

 ≤ 45

27

13 (48.1%)

14 (51.9%)

  

Histologic type

Squamous cell carcinoma

22

10 (45.5%)

12 (54.5%)

0.515

0.473

Adenocarcinoma

12

7 (58.3%)

5 (41.7%)

  

LNM

Yes

18

12 (66.7%)

6 (33.3%)

4.25

0.039*

No

16

5 (31.3%)

11 (68.8%)

  

FIGO stage

I

15

3 (20.0%)

12 (80.0%)

9.663

0.002*

II

19

14 (73.7%)

5 (26.3%)

  

Tumor size (cm)

 > 4

13

10 (76.9%)

3 (23.1%)

6.103

0.013*

 ≤ 4

21

7 (33.3%)

14 (66.7%)

  
  1. LNM lymph node metastasis, CC cervical cancer. *P < 0.05